No Data
These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley
Pfizer Sticks to 2025 Profit View as It Shrugs off Plunging Paxlovid Sales for COVID
Trump Reportedly Weighing a Move to Cut U.S. Drug Prices to International Levels
US Recession 'Countdown' Has Begun As Trump Tariffs Push Odds To 45%, Goldman Sachs Warns
Cantor Analyst rarely criticized the USA Secretary of Health, stating that "misguided decisions will backfire on the government's reputation," causing the Biotechnology Sector to plummet.
The financial services institution Cantor Fitzgerald's Biotechnology Analysts Josh Schimmer and Eric Schmidt rarely publicly criticized the leadership of USA Health Secretary Kennedy.
Heard on the Street: Biotech Investors Rush for the Exits After FDA Official Resigns -- WSJ